This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Nature's Plus Farmacêutica Ltda., Sigma Pharma Ltda.. Active years: 2011-2012.
Location History:
- Hortolandia, BR (2011)
- Hortolândia, BR (2012)
Company Filing History:
Years Active: 2011-2012
Title: Adriano Coelho: Innovator in Pharmaceutical Compositions
Introduction
Adriano Coelho is a notable inventor based in Hortolândia, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for sublingual administration. With a total of 2 patents, his work focuses on enhancing the efficacy of pharmaceutical compounds.
Latest Patents
Adriano's latest patents include a pharmaceutical composition based on an agonist of benzodiazepine. This invention describes the use of pharmaceutical compounds for sublingual administration, featuring active ingredients such as diazepam, lorazepam, and alprazolam, among others. The formulation consists of a mixture with at least 70% of the weight being a pharmaceutical excipient, including lactose, sorbitol, and cellulose.
Another significant patent is for sublingual formulations of ketorolac or its pharmaceutically acceptable salts. This invention aims to accelerate the pharmacological response to ketorolac without the need for injectable methods. The composition includes ketorolac as an active principle, representing 10 to 15% by weight, combined with a ternary mixture of lactose, sorbitol, and cellulose.
Career Highlights
Throughout his career, Adriano Coelho has worked with reputable companies such as Sigma Pharma Ltda. and Nature's Plus Farmacêutica Ltda. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Adriano has collaborated with notable professionals in the field, including Carlo Oliani and Heny Zaniboni. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Adriano Coelho stands out as an innovative inventor in the pharmaceutical industry, with a focus on improving drug delivery methods. His contributions through his patents reflect a commitment to advancing healthcare solutions.